key: cord-0078493-xdkwvksh authors: Bertrand, Dominique; Laurent, Charlotte; Lemée, Veronique; Lebourg, Ludivine; Hanoy, Mélanie; Le Roy, Frank; Nezam, Dorian; Pruteanu, Diana; Grange, Steven; de Nattes, Tristan; Lemoine, Mathilde; Candon, Sophie; Guerrot, Dominique title: Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients date: 2022-05-23 journal: Kidney Int DOI: 10.1016/j.kint.2022.05.007 sha: 6a492d91d3541abf20bf4e36bdc421156538cb6d doc_id: 78493 cord_uid: xdkwvksh nan Solid organ transplantation (SOT) recipients are at very high risk of developing severe COVID-19 1 . Despite the implementation of a third dose of mRNA vaccine, the efficacy of SARS-CoV-2 vaccination on humoral and cellular immunities is reduced in this population 2 , resulting in increased severe infections and mortality, including in fully vaccinated patients 3 . In this context, monoclonal antibodies (mAbs) providing passive immunization have been developed to enhance immunity against SARS-CoV-2 in immunocompromised patients 4 Dominique Bertrand designed the study; Dominique Guerrot and Dominique Bertrand wrote the paper; and all authors provided feedback and critical review. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients Occurrence of severe Covid-19 in vaccinated transplant patients Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19 Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies Correlates of protection against symptomatic and The authors wish to thank the health-care professionals of the University hospital of Rouen who were involved in the care of the patients, and particularly the nurse from the kidney transplant unit. We also thank Pr Manuel Etienne and Dr Damien Fuss for their help.Disclosures. The authors have no conflict of interest to disclose related to the work reported here.Funding. The authors declare no funding received for this work Data Availability Statement. All relevant data are within the paper.J o u r n a l P r e -p r o o f